Book a Meeting

Anti-CA9 Antibody, Highly Galactosylated (CAT#: BioBet-GA-090ZP) Datasheet

Target
CA9
Isotype
IgG1, κ
Description
Anti-CA9 Antibody, Highly Galactosylated (BioBet-GA-090ZP) is a chimeric IgG1, κ antibody against CA9 which contains with a high level of galactosylation.
Antibody Indication
Kidney tumours
Classification
Therapeutic antibody; biobetter

Cooperation Seeking

Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced CA9 antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Official Name
CA9
Alternative Names
CA9; carbonic anhydrase IX; carbonic anhydrase 9; CAIX; carbonic dehydratase; MN; RCC associated protein G250; pMW1; CA-IX; P54/58N; membrane antigen MN; carbonate dehydratase IX; RCC-associated antigen G250;
Gene ID
768
UniProt ID
Q16790
Cellular Localization
Plasma membrane, Nucleus
Genecards
1383
Involvement in Disease
Its related pathways are Celecoxib Pathway, Pharmacodynamics and Metabolism.
Related Pathways
Reversible hydration of carbon dioxide. Participates in pH regulation. May be involved in the control of cell proliferation and transformation. Appears to be a novel specific biomarker for a cervical neoplasia.
Field of research
Asn-346 bears high-mannose type glycan structures.
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Antibody Isotype
IgG1, κ
Antibody Clone
BioBet-GA-090ZP
Host
Chimeric
Species Reactivity
Human
Description
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant Chimeric antibody to Human CA9.
Antibody Indication
Kidney tumours

Kidney tumours

Related Products

Anti-CA9 Antibody, On-Target (CAT#: AES-0622-ZP794)
Anti-CA9 Antibody, Half-Life Extended (CAT#: AES-0622-ZP1122)
Highly Galactosylated Anti-CA9 (iodine (124I) girentuximab) Antibody (CAT#: BioBet-GA-091ZP)
Anti-CA9 Antibody, Recycling (CAT#: AES-0622-ZP138)
Anti-CA9 Antibody, FcγRIIB Binding Enhanced (CAT#: AES-0622-ZP466)
Non-fucosylated Anti-Human CA9 (iodine (124I) girentuximab) Therapeutic Antibody (CAT#: BioBet-091ZP)
Anti-CA9 Antibody, Non-Fucosylated (CAT#: BioBet-090ZP)

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK

Germany

ISO 9001 Certified - Creative Biolabs Quality Management System.